Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-19 4:43 pm Purchase | 2025-02-14 | 13D | BioRestorative Therapies, Inc. BRTX | Silva, Francisco | 1,196,819 15.100% | 432,262 (+56.54%) | Filing History |
| 2025-02-19 4:39 pm Purchase | 2025-02-14 | 13D | BioRestorative Therapies, Inc. BRTX | ALSTODT LANCE | 1,236,809 15.500% | 437,673 (+54.77%) | Filing History |
| 2025-02-19 07:54 am Unchanged | 2025-02-18 | 13G | BioRestorative Therapies, Inc. BRTX | Morrison Todd Hale | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-10 4:29 pm Unchanged | 2025-02-10 | 13G | BioRestorative Therapies, Inc. BRTX | Morrison Todd Hale | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-12-05 5:37 pm Sale | 2024-06-12 | 13G | BioRestorative Therapies, Inc. BRTX | Morrison Todd Hale | 0 0.000% | -550,000 (Position Closed) | Filing History |
| 2024-11-14 12:33 pm Purchase | 2024-09-30 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund Management LLC | 692,418 9.900% | 210,103 (+43.56%) | Filing History |
| 2024-06-21 6:33 pm Purchase | 2024-06-12 | 13G | BioRestorative Therapies, Inc. BRTX | Morrison Todd Hale | 550,000 8.100% | 550,000 (New Position) | Filing History |
| 2024-03-06 4:34 pm Purchase | 2024-02-08 | 13D | BioRestorative Therapies, Inc. BRTX | Broadrick Dale | 926,376 14.100% | 314,631 (+51.43%) | Filing History |
| 2024-02-15 4:43 pm Purchase | 2024-02-13 | 13D | BioRestorative Therapies, Inc. BRTX | Silva, Francisco | 764,557 10.700% | 764,557 (New Position) | Filing History |
| 2024-02-15 4:40 pm Purchase | 2024-02-13 | 13D | BioRestorative Therapies, Inc. BRTX | ALSTODT LANCE | 799,136 11.200% | 799,136 (New Position) | Filing History |
| 2024-02-14 1:44 pm Purchase | 2023-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund Management LLC | 482,315 9.900% | 106,311 (+28.27%) | Filing History |
| 2023-02-17 5:25 pm Purchase | 2023-02-17 | 13D | BioRestorative Therapies, Inc. BRTX | Silva, Francisco | 505,125 12.500% | 356,198 (+239.18%) | Filing History |
| 2023-02-17 5:24 pm Purchase | 2023-02-17 | 13D | BioRestorative Therapies, Inc. BRTX | ALSTODT LANCE | 513,784 12.700% | 362,366 (+239.32%) | Filing History |
| 2023-02-14 1:02 pm Purchase | 2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund Management LLC | 376,004 9.900% | 166,004 (+79.05%) | Filing History |
| 2023-02-07 4:42 pm Sale | 2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Hudson Bay Capital Management LP | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2022-07-14 5:26 pm Purchase | 2022-06-30 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund Management LLC | 210,000 5.800% | 210,000 (New Position) | Filing History |
| 2022-06-21 10:17 am Purchase | 2022-06-08 | 13D | BioRestorative Therapies, Inc. BRTX | Broadrick Dale | 611,745 16.800% | 41,561 (+7.29%) | Filing History |
| 2022-04-07 4:08 pm Purchase | 2022-04-05 | 13D | BioRestorative Therapies, Inc. BRTX | Broadrick Dale | 570,184 15.700% | 61,700 (+12.13%) | Filing History |
| 2022-03-29 4:46 pm Purchase | 2022-02-18 | 13D | BioRestorative Therapies, Inc. BRTX | Broadrick Dale | 508,484 14.600% | 508,484 (New Position) | Filing History |
| 2022-02-14 06:07 am Unchanged | 2021-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Altium Capital Management LLC | 200,000 4.990% | 0 (Unchanged) | Filing History |